Reporting salivary gland cytopathology—what’s new in Milan ed. 2?

The article discusses the use of cytologic material for ancillary studies in respiratory pathology and the second edition of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC). It emphasizes the importance of biomarker testing in cancer diagnostics and the advancements in nucleic acid-based techniques for molecular testing. The article also highlights the need for clinical and radiologic correlation in interpreting cytologic findings and the challenges in differentiating between low-grade carcinomas and benign tumors in salivary gland cytology. The MSRSGC provides updated guidelines for diagnosing and categorizing salivary gland neoplasms and will continue to evolve with advances in ancillary methods. [Extracted from the article]

Copyright of CAP Today is the property of College of American Pathologists and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)